Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Guardant Health, Inc. operates as a biotechnology company. The Company provides sequencing and cell diagnostics services for the cancer patients. Guardant Health serves patients worldwide.
Website: guardanthealth.com



Growth: Good revenue growth rate 38.7%, there is acceleration compared to average historical growth rates 28.0%. The revenue growth dynamics is stable Site traffic for the last 3 months showed a change of +141.5%

Profitability: LTM EBITDA margin is negative, -44.5%. On average the margin is improving steadily. Gross margin is high, +64.7%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 60% of quarters (showing a gain of -$0.27 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -0.8% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 614.0% higher than minimum and 2.2% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 0.9x by EV / Sales multiple , the company can be 93.3% overvalued

Insiders: For the last 3 months insiders sold company shares on $40.5 mln (-0.379% of cap.)

Key Financials (Download financials)

Ticker: GH
Share price, USD:  (0.0%)114.74
year average price 65.13  


year start price 44.47 2025-02-08

min close price 35.84 2025-03-10

max close price 117.28 2026-01-22

current price 114.74 2026-02-07
Common stocks: 101 923 002

Dividend Yield:  0.0%
EV / Sales: 13.8x
Margin (EBITDA LTM / Revenue): -44.5%
Fundamental value created in LTM:
Market Cap ($m): 11 695
Net Debt ($m): 720
EV (Enterprise Value): 12 415
Price to Book: -33.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-30fool.com

Should You Buy Guardant Health Before Feb. 19?

2026-01-26seekingalpha.com

Guardant Health: Look For Explosive Revenue Growth Ahead

2026-01-22benzinga.com

FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer

2026-01-22businesswire.com

Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

2026-01-18seekingalpha.com

Guardant Health: Shield Colorectal Cancer Screening To Sustain Growth

2026-01-12seekingalpha.com

Guardant Health, Inc. (GH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2025-12-04zacks.com

Is Guardant Health (GH) Stock Outpacing Its Medical Peers This Year?

2025-11-10businesswire.com

Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring

2025-11-05businesswire.com

Guardant Health Prices Upsized $350.0 Million Convertible Senior Notes Offering

2025-10-31seekingalpha.com

Guardant Health Beats Expectations: Shield, Quest, And AI Catalysts
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol GH GH GH GH GH GH GH GH GH GH GH GH GH GH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-10-29 2025-07-30 2024-11-06 2024-08-07 2024-05-09 2023-11-06 2023-08-03 2023-05-09 2022-11-03
acceptedDate 2025-10-29 17:13:13 2025-07-30 17:13:33 2025-02-20 17:17:57 2024-11-06 17:12:45 2024-08-07 17:12:53 2024-05-09 16:59:52 2024-02-22 17:23:38 2023-11-06 16:58:53 2023-08-03 17:02:11 2023-05-09 17:00:24 2023-02-23 17:00:52 2022-11-03 17:13:19 2022-02-24 17:00:06 2021-02-25 16:36:12
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 265M 232M 739M 191M 177M 168M 564M 143M 137M 129M 450M 117M 374M 287M
costOfRevenue 94M 81M 290M 74M 72M 65M 227M 58M 54M 53M 156M 40M 123M 93M
grossProfit 172M 151M 449M 117M 105M 103M 337M 85M 83M 76M 293M 77M 251M 194M
grossProfitRatio 0.647 0.65 0.611 0.591 0.612 0.597 0.607 0.588 0.655
researchAndDevelopmentExpenses 90M 87M 348M 87M 83M 84M 367M 94M 90M 93M 374M 100M 263M 150M
generalAndAdministrativeExpenses 53M 50M 180M 49M 40M 39M 156M 36M 42M 40M 164M 41M 207M 193M
sellingAndMarketingExpenses 127M 120M 365M 98M 82M 80M 295M 69M 71M 76M 300M 80M 192M 107M
sellingGeneralAndAdministrativeExpenses 181M 170M 545M 147M 122M 119M 451M 105M 113M 117M 464M 121M 399M 299M
otherExpenses 0 0 0 0 -15M -29M 83M 17M 41M -2M 0 0 0 0
operatingExpenses 271M 257M 893M 234M 205M 203M 902M 199M 203M 210M 838M 222M 662M 449M
costAndExpenses 364M 339M 1 183M 309M 278M 268M 1 129M 257M 257M 263M 994M 262M 785M 542M
interestIncome 7M 8M 54M 13M 14M 15M 35M 12M 7M 3M 6M 2M 4M 10M
interestExpense 943 000 983 000 3M 646 000 645 000 645 000 3M 644 000 645 000 644 000 3M 644 000 3M 5M
depreciationAndAmortization 9M 10M 42M 11M 11M 11M 43M 11M 48M 1M 36M -7M 22M 16M
ebitda -82M -89M -390M -96M -91M -89M -433M -74M -72M -133M -615M -151M -360M -225M
ebitdaratio -0.31 -0.383 -0.504 -0.507 -0.528 -0.517 -0.522 -1.031 -1.29
operatingIncome -99M -106M -444M -117M -101M -100M -565M -114M -120M -134M -544M -145M -411M -255M
operatingIncomeRatio -0.373 -0.459 -0.613 -0.568 -0.592 -0.794 -0.872 -1.041 -1.232
totalOtherIncomeExpensesNet 6M 7M 9M 10M -2M -15M 86M 17M 41M 762 000 -109M -17M 27M 9M
incomeBeforeTax -93M -100M -435M -108M -102M -115M -479M -86M -72M -133M -653M -162M -384M -246M
incomeBeforeTaxRatio -0.349 -0.43 -0.563 -0.578 -0.68 -0.599 -0.527 -1.036 -1.379
incomeTaxExpense 136 000 38 000 1M 30 000 133 000 405 000 685 000 490 000 496 000 240 000 1M 115 000 300 000 379 000
netIncome -93M -100M -436M -108M -103M -115M -479M -86M -73M -134M -655M -162M -406M -254M
netIncomeRatio -0.35 -0.43 -0.563 -0.579 -0.682 -0.602 -0.531 -1.037 -1.38
eps -0.74 -0.8 -3.56 -0.88 -0.84 -0.94 -4.28 -0.73 -0.67 -1.3 -6.41 -1.58 -3.8 -2.53
epsdiluted -0.74 -0.8 -0.88 -0.84 -0.94 -0.73 -0.67 -1.3 -1.58
weightedAverageShsOut 125M 124M 123M 123M 122M 122M 112M 118M 109M 103M 102M 102M 101M 98M
weightedAverageShsOutDil 125M 124M 123M 123M 122M 122M 112M 118M 109M 103M 102M 102M 101M 98M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-20 2024-02-22 2023-02-23 2022-02-24 2021-02-25
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 51M 33M 3M 1M 5M
ebit -433M -476M -651M -382M -241M
nonOperatingIncomeExcludingInterest -11M -89M 106M -29M -14M
netIncomeFromContinuingOperations -436M -479M -655M -385M -246M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -436M -479M -655M -406M -254M
epsDiluted -3.56 -4.28 -6.41 -3.8 -2.53

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol GH GH GH GH GH GH GH GH GH GH GH GH GH GH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-10-29 2025-07-30 2024-11-06 2024-08-07 2024-05-09 2023-11-06 2023-08-03 2023-05-09 2022-11-03
acceptedDate 2025-10-29 17:13:13 2025-07-30 17:13:33 2025-02-20 17:17:57 2024-11-06 17:12:45 2024-08-07 17:12:53 2024-05-09 16:59:52 2024-02-22 17:23:38 2023-11-06 16:58:53 2023-08-03 17:02:11 2023-05-09 17:00:24 2023-02-23 17:00:52 2022-11-03 17:13:19 2022-02-24 17:00:06 2021-02-25 16:36:12
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 580M 629M 526M 688M 1 035M 1 129M 1 134M 457M 271M 224M 142M 158M 492M 833M
shortTermInvestments 0 0 314M 311M 52M 0 35M 697M 954M 713M 870M 800M 441M 962M
cashAndShortTermInvestments 580M 629M 840M 999M 1 035M 1 129M 1 169M 1 155M 1 225M 937M 1 011M 958M 933M 1 795M
netReceivables 116M 130M 110M 88M 101M 85M 89M 89M 86M 87M 97M 86M 98M 53M
inventory 90M 84M 71M 72M 67M 63M 62M 77M 61M 46M 52M 63M 31M 23M
otherCurrentAssets 43M 40M 34M 67M 87M 32M 28M 26M 26M 34M 32M 24M 0 0
totalCurrentAssets 829M 883M 1 055M 1 227M 1 290M 1 309M 1 347M 1 347M 1 398M 1 104M 1 192M 1 131M 1 114M 1 888M
propertyPlantEquipmentNet 288M 296M 279M 270M 278M 290M 303M 309M 321M 334M 342M 347M 314M 100M
goodwill 3M 3M 3M 3M 3M 3M 3M 3M 3M 3M 3M 3M 3M 3M
intangibleAssets 5M 6M 7M 7M 8M 8M 9M 10M 10M 11M 12M 12M 14M 16M
goodwillAndIntangibleAssets 9M 9M 10M 11M 11M 12M 12M 13M 14M 14M 15M 16M 17M 19M
longTermInvestments 130M 122M 0 0 11M 77M 0 24 000 0 0 0 157M 698M 247M
taxAssets 0 0 0 0 0 -1 0 -24 000 0 0 0 0 0 0
otherNonCurrentAssets 21M 21M 141M 31M 19M 18M 124M 128M 108M 59M 61M 52M 61M 17M
totalNonCurrentAssets 448M 449M 430M 312M 319M 396M 439M 450M 442M 407M 418M 571M 1 090M 383M
otherAssets 0 0 0 0 0 1 0 0 0 0 0 0 0 0
totalAssets 1 277M 1 332M 1 486M 1 539M 1 609M 1 705M 1 786M 1 797M 1 840M 1 512M 1 610M 1 702M 2 204M 2 272M
accountPayables 20M 45M 39M 15M 42M 38M 52M 78M 80M 67M 69M 41M 39M 7M
shortTermDebt 26M 26M 29M 27M 28M 28M 0 26M 25M 24M 0 20M 0 0
taxPayables 0 0 0 0 0 0 0 0 0 0 0 4M 4M 5M
deferredRevenue 47M 54M 35M 30M 29M 23M 18M 21M 12M 14M 17M 13M 11M 9M
otherCurrentLiabilities 144M 113M 39M 125M 102M 132M 73M 101M 84M 100M 56M 100M 120M 28M
totalCurrentLiabilities 237M 238M 226M 197M 202M 220M 206M 227M 201M 204M 193M 175M 195M 67M
longTermDebt 1 300M 1 308M 1 143M 1 312M 1 313M 1 141M 1 140M 1 332M 1 337M 1 343M 1 137M 1 353M 1 135M 806M
deferredRevenueNonCurrent 0 0 0 0 6M 5M 0 3M 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 172M 179M 0 -3M 0 0 0 0 0 0
otherNonCurrentLiabilities 94M 91M 93M 89M 96M 91M 96M 10M 9M 9M 9M 1 285M 4M 2M
totalNonCurrentLiabilities 1 394M 1 399M 1 400M 1 401M 1 409M 1 416M 1 422M 1 342M 1 346M 1 352M 1 357M 1 360M 1 365M 849M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 185M 192M 164M 198M 200M 179M 214M 219M 198M 205M 232M 237M 239M 48M
totalLiabilities 1 631M 1 637M 1 625M 1 599M 1 611M 1 636M 1 628M 1 569M 1 547M 1 556M 1 550M 1 535M 1 559M 916M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000
retainedEarnings -2 866M -2 773M -2 578M -2 467M -2 359M -2 257M -2 142M -1 955M -1 869M -1 796M -1 662M -1 522M -1 008M -607M
accumulatedOtherComprehensiveIncomeLoss -4M -4M -5M -3M -6M -5M -4M -6M -8M -12M -20M -27M -5M 3M
othertotalStockholdersEquity 2 516M 2 472M 2 410M 2 364M 2 330M 2 189M 2 170M 1 764M 1 716M
totalStockholdersEquity -354M -305M -140M -60M -2M 68M 159M 228M 293M -45M 60M 167M 645M 1 298M
totalEquity -354M -305M -140M -60M -2M 68M 159M 228M 293M -45M 60M 167M 645M 1 356M
totalLiabilitiesAndStockholdersEquity 1 277M 1 332M 1 539M 1 609M 1 705M 1 797M 1 840M 1 512M 1 702M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 57M
totalLiabilitiesAndTotalEquity 1 277M 1 332M 1 486M 1 539M 1 609M 1 705M 1 786M 1 797M 1 840M 1 512M 1 610M 1 702M 2 204M 2 272M
totalInvestments 130M 122M 314M 311M 11M 77M 35M 697M 954M 713M 870M 956M 1 139M 1 209M
totalDebt 1 326M 1 334M 1 336M 1 339M 1 341M 1 347M 1 354M 1 358M 1 337M 1 343M 1 369M 1 373M 1 374M 854M
netDebt 746M 705M 811M 651M 306M 218M 220M 901M 1 066M 1 119M 1 228M 1 215M 882M 22M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-20 2024-02-22 2023-02-23 2022-02-24 2021-02-25
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 107M 84M 97M 98M 53M
otherReceivables 3M 5M 0 0 0
prepaids 0 0 0 53M 17M
totalPayables 39M 52M 69M 39M 12M
otherPayables 0 0 0 0 5M
accruedExpenses 83M 36M 29M 11M 11M
capitalLeaseObligationsCurrent 0 28M 22M 13M 7M
capitalLeaseObligationsNonCurrent 164M 186M 210M 226M 42M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 2 444M 2 304M 1 742M 1 658M 1 902M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol GH GH GH GH GH GH GH GH GH GH GH GH GH GH
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-10-29 2025-07-30 2024-11-06 2024-08-07 2024-05-09 2023-11-06 2023-08-03 2023-05-09 2022-11-03
acceptedDate 2025-10-29 17:13:13 2025-07-30 17:13:33 2025-02-20 17:17:57 2024-11-06 17:12:45 2024-08-07 17:12:53 2024-05-09 16:59:52 2024-02-22 17:23:38 2023-11-06 16:58:53 2023-08-03 17:02:11 2023-05-09 17:00:24 2023-02-23 17:00:52 2022-11-03 17:13:19 2022-02-24 17:00:06 2021-02-25 16:36:12
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -93M -100M -436M -108M -103M -115M -479M -86M -73M -134M -655M -162M -385M -246M
depreciationAndAmortization 9M 10M 42M 11M 11M 11M 43M 11M 11M 10M 36M 10M 22M 16M
deferredIncomeTax 0 0 0 0 0 0 0 -24M -43M 0 0 0 0 0
stockBasedCompensation 43M 42M 140M 50M 27M 27M 91M 22M 22M 22M 95M 21M 151M 144M
changeInWorkingCapital -3M -20M -61M 46M -54M 8M 54M -8M -20M 18M 62M 27M -40M -48M
accountsReceivables 14M -14M -21M 12M -16M 4M 8M -2M -2M 12M 375 000 9M -44M -5M
inventory -6M -7M -9M -5M -4M -1M -10M -17M -14M 5M -21M -3M -8M -8M
accountsPayables 3M -3M -3M -5M -28M 13M 0 1M -3M 14M 60M 7M 9M -8M
otherWorkingCapital -14M 4M -28M 44M -5M -9M 56M 9M -2M -13M 22M 15M 3M -27M
otherNonCashItems 8M 7M 75M -49M 121M 71M -33M 8M 8M 8M 153M 26M 43M 30M
netCashProvidedByOperatingActivities -35M -60M -240M -51M -94M -30M -325M -78M -94M -74M -309M -78M -209M -104M
investmentsInPropertyPlantAndEquipment -10M -6M -35M -4M -5M -7M -20M -2M -7M -8M -77M -22M -75M -36M
acquisitionsNet 0 0 0 0 0 0 0 -263M 0 0 0 0 0 0
purchasesOfInvestments -9M 0 -315M -310M 0 0 -635M -73M -499M -63M -328M 0 -940M -1 126M
salesMaturitiesOfInvestments 0 0 89M 19M 0 35M 1 496M 336M 265M 228M 555M 63M 952M 563M
otherInvestingActivites 5M -5M 0 0 35M 263M 0 0 0
netCashUsedForInvestingActivites -14M -11M -295M -5M 28M 261M -241M 157M 41M
debtRepayment 0 -44 000 0 0 0 -37 000 -19 000 -18 000 -18 000
commonStockIssued 4M 9M -10M 10M 213 000 8M 381M 157 000 0
commonStockRepurchased 0 0 0 2M 7M -2M 0 -3M 7M 0 0 0 0 0
dividendsPaid 0 0 0 0 0 -5M -21M 0 0
otherFinancingActivites 610 000 -8M -3M 6M -1M 4M 17M -993 000 -19M
netCashUsedProvidedByFinancingActivities 4M 2M -3M 6M -1M 4M 384M -854 000 -19M
effectOfForexChangesOnCash -533 000 937 000 -2M 2M -837 000 -1M -911 000 -526 000 -1M -163 000 -2M -529 000 -2M 455 000
netChangeInCash -46M -68M -504M -347M -94M -4M 992M 186M 47M 82M -350M -57M -341M 690M
cashAtEndOfPeriod 690M 735M 630M 688M 1 035M 1 129M 1 134M 457M 271M 224M 142M 159M 492M 833M
cashAtBeginningOfPeriod 735M 804M 1 134M 1 035M 1 129M 1 134M 142M 271M 224M 142M 492M 215M 833M 143M
operatingCashFlow -35M -60M -240M -51M -94M -30M -325M -78M -94M -74M -309M -78M -209M -104M
capitalExpenditure -10M -6M -35M -4M -5M -7M -20M -2M -7M -8M -77M -22M -75M -54M
freeCashFlow -46M -66M -275M -55M -99M -37M -345M -80M -101M -82M -387M -100M -284M -158M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-20 2024-02-22 2023-02-23 2022-02-24 2021-02-25
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 0 0 -18M
netCashProvidedByInvestingActivities -261M 840M 150M -63M -617M
netDebtIssuance 0 0 -71 000 -146 000 1 133M
longTermNetDebtIssuance 0 0 -71 000 -146 000 1 133M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 15M 493M 0 0 356M
netCommonStockIssuance 15M 493M 0 0 356M
commonStockIssuance 15M 493M 0 0 356M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -16M -16M -189M -67M -78M
netCashProvidedByFinancingActivities -996 000 477M -189M -67M 1 410M
incomeTaxesPaid 1M 2M 1M 393 000 331 000
interestPaid 0 0 0 0 0

Earning call transcript

2025 q3
2025-10-30 ET (fiscal 2025 q3)
2025 q2
2025-07-31 ET (fiscal 2025 q2)
2025 q1
2025-04-30 ET (fiscal 2025 q1)
2024 q4
2025-02-20 ET (fiscal 2024 q4)
2024 q3
2024-11-06 ET (fiscal 2024 q3)
2024 q2
2024-08-07 ET (fiscal 2024 q2)
2024 q1
2024-05-10 ET (fiscal 2024 q1)
2023 q4
2024-02-22 ET (fiscal 2023 q4)
2023 q3
2023-11-06 ET (fiscal 2023 q3)
2023 q2
2023-08-03 ET (fiscal 2023 q2)
2023 q1
2023-05-09 ET (fiscal 2023 q1)
2022 q4
2023-02-23 ET (fiscal 2022 q4)
2022 q3
2022-11-03 ET (fiscal 2022 q3)
2022 q2
2022-08-04 ET (fiscal 2022 q2)
2022 q1
2022-05-05 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-10-29 21:13 ET
Guardant Health reported for 2025 q3
SEC form 8
2025-10-29 20:07 ET
Guardant Health published news for 2025 q3
SEC form 8
2025-10-29 20:07 ET
Guardant Health reported for 2025 q3
SEC form 10
2025-07-30 21:13 ET
Guardant Health reported for 2025 q2
SEC form 8
2025-07-30 20:08 ET
Guardant Health published news for 2025 q2
SEC form 8
2025-07-30 20:08 ET
Guardant Health reported for 2025 q2
SEC form 10
2025-04-30 00:00 ET
Guardant Health published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
Guardant Health published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
Guardant Health reported for 2025 q1
SEC form 10
2025-02-20 17:17 ET
Guardant Health published news for 2024 q4
SEC form 8
2025-02-20 16:11 ET
Guardant Health published news for 2024 q4
SEC form 8
2025-02-20 16:11 ET
Guardant Health reported for 2024 q4
SEC form 10
2025-02-20 00:00 ET
Guardant Health published news for 2024 q4
SEC form 8
2025-01-13 00:00 ET
Guardant Health published news for 2024 q4
SEC form 8
2025-01-13 00:00 ET
Guardant Health published news for 2024 q4
SEC form 10
2024-11-06 17:12 ET
Guardant Health published news for 2024 q3
SEC form 8
2024-11-06 16:08 ET
Guardant Health published news for 2024 q3
SEC form 8
2024-11-06 16:08 ET
Guardant Health published news for 2024 q3
SEC form 10
2024-08-07 17:12 ET
Guardant Health reported for 2024 q2
SEC form 8
2024-08-07 16:09 ET
Guardant Health published news for 2024 q2
SEC form 8
2024-08-07 16:09 ET
Guardant Health reported for 2024 q2
SEC form 10
2024-08-07 00:00 ET
Guardant Health published news for 2024 q2
SEC form 10
2024-05-09 00:00 ET
Guardant Health published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Guardant Health published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Guardant Health reported for 2024 q1
SEC form 10
2024-02-22 17:23 ET
Guardant Health published news for 2023 q4
SEC form 8
2024-02-22 16:10 ET
Guardant Health published news for 2023 q4
SEC form 8
2024-02-22 16:10 ET
Guardant Health reported for 2023 q4
SEC form 10
2024-02-22 00:00 ET
Guardant Health published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Guardant Health published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Guardant Health published news for 2023 q4
SEC form 10
2023-11-06 16:58 ET
Guardant Health published news for 2023 q3
SEC form 8
2023-11-06 16:10 ET
Guardant Health reported for 2023 q3
SEC form 10
2023-11-06 00:00 ET
Guardant Health published news for 2023 q3
SEC form 10
2023-08-03 17:02 ET
Guardant Health published news for 2023 q2
SEC form 6
2023-08-03 16:14 ET
Guardant Health reported for 2023 q2
SEC form 10
2023-08-03 00:00 ET
Guardant Health published news for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Guardant Health published news for 2023 q2
SEC form 6
2023-08-01 16:15 ET
Guardant Health published news for 2023 q2
SEC form 6
2023-06-20 16:08 ET
Guardant Health published news for 2023 q1
SEC form 10
2023-05-09 00:00 ET
Guardant Health published news for 2023 q1
SEC form 8
2023-05-09 00:00 ET
Guardant Health reported for 2023 q1
SEC form 6
2023-04-10 16:58 ET
Guardant Health published news for 2023 q1
SEC form 6
2023-03-10 21:05 ET
Guardant Health published news for 2022 q4
SEC form 6
2023-03-07 17:09 ET
Guardant Health published news for 2022 q4
SEC form 6
2023-02-27 16:10 ET
Guardant Health published news for 2022 q4
SEC form 10
2023-02-23 17:00 ET
Guardant Health reported for 2022 q4
SEC form 6
2023-02-23 16:12 ET
Guardant Health published news for 2022 q4
SEC form 10
2023-02-23 00:00 ET
Guardant Health reported for 2022 q4
SEC form 8
2023-02-23 00:00 ET
Guardant Health reported for 2022 q4
SEC form 6
2023-01-09 08:08 ET
Guardant Health published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Guardant Health published news for 2022 q4
SEC form 6
2022-12-15 16:17 ET
Guardant Health published news for 2022 q3
SEC form 10
2022-11-03 17:13 ET
Guardant Health reported for 2022 q3
SEC form 6
2022-11-03 16:11 ET
Guardant Health published news for 2022 q3
SEC form 10
2022-11-03 00:00 ET
Guardant Health reported for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Guardant Health reported for 2022 q3
SEC form 6
2022-08-12 16:13 ET
Guardant Health published news for 2022 q2
SEC form 6
2022-08-11 16:12 ET
Guardant Health published news for 2022 q2
SEC form 10
2022-08-04 17:03 ET
Guardant Health reported for 2022 q2
SEC form 6
2022-08-04 16:14 ET
Guardant Health published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
Guardant Health reported for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Guardant Health reported for 2022 q2
SEC form 6
2022-07-11 17:03 ET
Guardant Health published news for 2022 q2
SEC form 6
2022-07-07 08:08 ET
Guardant Health published news for 2022 q2
SEC form 6
2022-06-21 07:01 ET
Guardant Health published news for 2022 q1
SEC form 6
2022-06-13 08:05 ET
Guardant Health published news for 2022 q1
SEC form 6
2022-05-05 18:01 ET
Guardant Health published news for 2022 q1
SEC form 10
2022-05-05 17:14 ET
Guardant Health reported for 2022 q1
SEC form 6
2022-05-05 16:20 ET
Guardant Health published news for 2022 q1
SEC form 10
2022-05-05 00:00 ET
Guardant Health reported for 2022 q1
SEC form 8
2022-05-05 00:00 ET
Guardant Health reported for 2022 q1
SEC form 6
2022-04-28 16:11 ET
Guardant Health published news for 2022 q1
SEC form 6
2022-02-28 17:14 ET
Guardant Health published news for 2021 q4
SEC form 10
2022-02-24 17:00 ET
Guardant Health published news for 2021 q4
SEC form 10
2022-02-24 00:00 ET
Guardant Health published news for 2021 q4
SEC form 6
2022-02-23 16:11 ET
Guardant Health published news for 2021 q4
SEC form 8
2022-02-23 00:00 ET
Guardant Health published news for 2021 q4
SEC form 6
2022-01-07 17:15 ET
Guardant Health published news for 2021 q4
SEC form 10
2021-11-04 17:08 ET
Guardant Health published news for 2021 q3
SEC form 6
2021-11-04 16:17 ET
Guardant Health published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
Guardant Health published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
Guardant Health published news for 2021 q3
SEC form 6
2021-10-27 17:00 ET
Guardant Health published news for 2021 q3
SEC form 6
2021-10-20 16:30 ET
Guardant Health published news for 2021 q3
SEC form 6
2021-08-06 17:05 ET
Guardant Health published news for 2021 q2
SEC form 10
2021-08-05 16:29 ET
Guardant Health published news for 2021 q2
SEC form 6
2021-08-05 16:12 ET
Guardant Health published news for 2021 q2
SEC form 6
2021-08-05 16:09 ET
Guardant Health published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
Guardant Health published news for 2021 q2
SEC form 8
2021-08-05 00:00 ET
Guardant Health published news for 2021 q2
SEC form 6
2021-07-08 17:05 ET
Guardant Health published news for 2021 q2
SEC form 6
2021-06-21 16:06 ET
Guardant Health published news for 2021 q1
SEC form 6
2021-05-17 08:30 ET
Guardant Health published news for 2021 q1
SEC form 6
2021-05-13 19:39 ET
Guardant Health published news for 2021 q1
SEC form 10
2021-05-06 17:09 ET
Guardant Health published news for 2021 q1
SEC form 6
2021-05-06 16:17 ET
Guardant Health published news for 2021 q1
SEC form 10
2021-05-06 00:00 ET
Guardant Health published news for 2021 q1
SEC form 8
2021-05-06 00:00 ET
Guardant Health published news for 2021 q1
SEC form 6
2021-04-29 16:44 ET
Guardant Health published news for 2021 q1
SEC form 10
2021-02-25 16:36 ET
Guardant Health published news for 2020 q4
SEC form 6
2021-02-24 16:11 ET
Guardant Health published news for 2020 q4
SEC form 6
2021-01-11 10:40 ET
Guardant Health published news for 2020 q4
SEC form 6
2021-01-07 16:49 ET
Guardant Health published news for 2020 q4
SEC form 6
2021-01-07 16:01 ET
Guardant Health published news for 2020 q4
SEC form 6
2020-12-11 17:00 ET
Guardant Health published news for 2020 q3
SEC form 6
2020-11-19 21:43 ET
Guardant Health published news for 2020 q3
SEC form 6
2020-11-17 16:10 ET
Guardant Health published news for 2020 q3
SEC form 10
2020-11-05 16:27 ET
Guardant Health published news for 2020 q3
SEC form 6
2020-11-05 16:14 ET
Guardant Health published news for 2020 q3
SEC form 6
2020-10-09 20:25 ET
Guardant Health published news for 2020 q3
SEC form 6
2020-10-06 16:02 ET
Guardant Health published news for 2020 q3